Home › Cardiomyopathy › Missouri › St. Louis
Cardiomyopathy clinical trials in St. Louis, MO
6 studies for Cardiomyopathy are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RecruitingPhase 3
- Clinical Trial Site, St Louis
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RecruitingObservational study
- Clinical Trial Site, St Louis
Clinical Course Of Disease In Participants With FA-CM
RecruitingObservational study
- Washington University School of Medicine in St. Louis, St Louis
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Washington University in St. Louis, St Louis
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
RecruitingPhase 4
- Washington University in St. Louis, St Louis
Danon Disease Natural History Study
RecruitingObservational study
- Washington University, St Louis
About Cardiomyopathy
Cardiomyopathy is a disease that causes the heart to become enlarged, thick, or stiff. Read about the different types, their symptoms, and treatments.
More about Cardiomyopathy on MedlinePlus
Cardiomyopathy trials in other cities
- New York City, NY10 studies
- Boston, MA9 studies
- Rochester, MN8 studies
- Washington, DC8 studies
- San Diego, CA7 studies
- Baltimore, MD7 studies
- Charleston, SC6 studies
- Indianapolis, IN6 studies
- Richmond, VA6 studies
- Dallas, TX6 studies
- Philadelphia, PA6 studies
- Chicago, IL5 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.